These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21338051)

  • 21. Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.
    Sheffler DJ; Pinkerton AB; Dahl R; Markou A; Cosford ND
    ACS Chem Neurosci; 2011 Aug; 2(8):382-93. PubMed ID: 22860167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected 'molecular switch' from a closely related mGlu4 positive allosteric modulator.
    Utley T; Haddenham D; Salovich JM; Zamorano R; Vinson PN; Lindsley CW; Hopkins CR; Niswender CM
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6955-9. PubMed ID: 22030026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Acyl-N'-arylpiperazines as negative allosteric modulators of mGlu1: identification of VU0469650, a potent and selective tool compound with CNS exposure in rats.
    Lovell KM; Felts AS; Rodriguez AL; Venable DF; Cho HP; Morrison RD; Byers FW; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3713-8. PubMed ID: 23727046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in rats.
    Felts AS; Lindsley SR; Lamb JP; Rodriguez AL; Menon UN; Jadhav S; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4390-4. PubMed ID: 20598884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel class of positive allosteric modulators of metabotropic glutamate receptor subtype 1 interact with a site distinct from that of negative allosteric modulators.
    Hemstapat K; de Paulis T; Chen Y; Brady AE; Grover VK; Alagille D; Tamagnan GD; Conn PJ
    Mol Pharmacol; 2006 Aug; 70(2):616-26. PubMed ID: 16645124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR.
    Garcia-Barrantes PM; Cho HP; Starr TM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 May; 26(9):2289-92. PubMed ID: 27013388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5).
    Williams DL; Lindsley CW
    Curr Top Med Chem; 2005; 5(9):825-46. PubMed ID: 16178729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The discovery of VU0652957 (VU2957, Valiglurax): SAR and DMPK challenges en route to an mGlu
    Panarese JD; Engers DW; Wu YJ; Guernon JM; Chun A; Gregro AR; Bender AM; Capstick RA; Wieting JM; Bronson JJ; Macor JE; Westphal R; Soars M; Engers JE; Felts AS; Rodriguez AL; Emmitte KA; Jones CK; Blobaum AL; Conn PJ; Niswender CM; Hopkins CR; Lindsley CW
    Bioorg Med Chem Lett; 2019 Jan; 29(2):342-346. PubMed ID: 30503632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.
    Bennett KA; Christopher JA; Tehan BG
    Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor.
    Tresadern G; Cid JM; Macdonald GJ; Vega JA; de Lucas AI; García A; Matesanz E; Linares ML; Oehlrich D; Lavreysen H; Biesmans I; Trabanco AA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):175-9. PubMed ID: 19932615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators.
    Niswender CM; Lebois EP; Luo Q; Kim K; Muchalski H; Yin H; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5626-30. PubMed ID: 18793851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
    Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 2: SAR of alternative 3-methyl heterocycles and progress towards an in vivo tool.
    Garcia-Barrantes PM; Cho HP; Metts AM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 Feb; 26(3):751-756. PubMed ID: 26778256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats.
    Engers DW; Field JR; Le U; Zhou Y; Bolinger JD; Zamorano R; Blobaum AL; Jones CK; Jadhav S; Weaver CD; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2011 Feb; 54(4):1106-10. PubMed ID: 21247167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
    Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossover.
    Manka JT; Vinson PN; Gregory KJ; Zhou Y; Williams R; Gogi K; Days E; Jadhav S; Herman EJ; Lavreysen H; Mackie C; Bartolomé JM; Macdonald GJ; Steckler T; Daniels JS; Weaver CD; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6481-5. PubMed ID: 22981332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator.
    Spear N; Gadient RA; Wilkins DE; Do M; Smith JS; Zeller KL; Schroeder P; Zhang M; Arora J; Chhajlani V
    Eur J Pharmacol; 2011 Jun; 659(2-3):146-54. PubMed ID: 21335002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional selectivity induced by mGlu₄ receptor positive allosteric modulation and concomitant activation of Gq coupled receptors.
    Yin S; Zamorano R; Conn PJ; Niswender CM
    Neuropharmacology; 2013 Mar; 66():122-32. PubMed ID: 22426233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor.
    Pérez-Benito L; Doornbos MLJ; Cordomí A; Peeters L; Lavreysen H; Pardo L; Tresadern G
    Structure; 2017 Jul; 25(7):1153-1162.e4. PubMed ID: 28648611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.